Skip to content

(7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]methanone

C17H24N6O — CID 167829069

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC(7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]methanone
SMILESCC1CCn2c(C(=O)N3CCN(Cc4cn[nH]c4)CC3)cnc2C1
InChIInChI=1S/C17H24N6O/c1-13-2-3-23-15(11-18-16(23)8-13)17(24)22-6-4-21(5-7-22)12-14-9-19-20-10-14/h9-11,13H,2-8,12H2,1H3,(H,19,20)
InChIKeyLENLTHXIJMIKCE-UHFFFAOYSA-N
MW328.42 g/mol
LogP1.15
Rot. Bonds3

About (7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]methanone

(7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]methanone (PubChem CID 167829069) has the molecular formula C17H24N6O and a molecular weight of 328.42 g/mol. Its IUPAC name is (7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]methanone.

Molecular Properties

Compound Name(7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]methanone
PubChem CID167829069
Molecular FormulaC17H24N6O
Molecular Weight328.42 g/mol
Exact Mass328.20
IUPAC Name(7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]methanone
SMILESCC1CCn2c(C(=O)N3CCN(Cc4cn[nH]c4)CC3)cnc2C1
InChIInChI=1S/C17H24N6O/c1-13-2-3-23-15(11-18-16(23)8-13)17(24)22-6-4-21(5-7-22)12-14-9-19-20-10-14/h9-11,13H,2-8,12H2,1H3,(H,19,20)
InChIKeyLENLTHXIJMIKCE-UHFFFAOYSA-N
XLogP1.15
TPSA70.05 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds3
Heavy Atoms24
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500328.42
LogP ≤ 51.15
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze (7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]methanone?
The IUPAC name of (7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]methanone (CID 167829069) is (7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]methanone.
What is the SMILES notation for (7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]methanone?
The canonical SMILES for (7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]methanone is CC1CCn2c(C(=O)N3CCN(Cc4cn[nH]c4)CC3)cnc2C1.
What is the InChIKey of (7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]methanone?
The InChIKey is LENLTHXIJMIKCE-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H24N6O/c1-13-2-3-23-15(11-18-16(23)8-13)17(24)22-6-4-21(5-7-22)12-14-9-19-20-10-14/h9-11,13H,2-8,12H2,1H3,(H,19,20).
What are the key properties of (7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]methanone?
(7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]methanone has a molecular weight of 328.42 g/mol, XLogP of 1.15, 3 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (7-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-3-yl)-[4-(1H-pyrazol-4-ylmethyl)piperazin-1-yl]methanone is sourced from PubChem (CID 167829069), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.